Bruce Loveland is a cellular immunologist interested in the immune repertoire and how immune responses develop, are expressed and change. He has focused on studies of immune effector cells and the underlying genetic, molecular and physiological basis of immunity in organ transplantation, autoimmunity and viral immune responses. His career experience includes working at Melbourne University (PhD 1981), in London (MRC Clinical Research Centre, Harrow), Dallas (Howard Hughes Institute) and returning to Monash University, the Austin Research Institute (as NHMRC Senior Research Fellow, 1996-2004) and Burnet Institute.
Bruce has extensive experience in project and facilities management, cGLP and cGMP requirements, and in translational medical research with technical transfer from research laboratory to clinical trials, particularly for xenotransplantation and for cellular immunotherapies with Phase I and II clinical trials for cancer and persistent hepatitis C infection.
A major commitment with Associate Professor Rosemary Ffrench at Burnet Institute has been the establishment (2008) and expansion of the Burnet Immuno Monitoring Facility Burnet (IMF), with quality management and deputy director roles. He is currently a Senior Fellow and Head, Research Support and Facilities at Burnet Institute.
- 2015: Scientific Advisory Board, 360biolabs